Barclays analyst Andrew Mok Friday morning upgraded Universal Health to Overweight from Equal Weight with a price target of $256, up from $198. The company’s “strong” Q2 results drive greater conviction in continued margin expansion supported by well-controlled labor costs, solid volumes, and favorable reimbursement, the analyst tells investors in a research note. The firm now sees multiples path to upside for the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health price target raised to $220 from $183 at TD Cowen
- Universal Health upgraded to Neutral from Underweight at Cantor Fitzgerald
- Universal Health upgraded to Overweight from Equal Weight at Barclays
- UHS Earnings: Universal Health Jumps after Huge EPS, Guidance Beats
- UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES 2024 SECOND QUARTER FINANCIAL RESULTS, INCREASES 2024 FULL YEAR OPERATING RESULTS FORECAST AND ANNOUNCES $1 BILLION INCREASE TO STOCK REPURCHASE PROGRAM AUTHORIZATION